Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tecfidera neuroprotection mechanism in MS
NCT03092544Phase 4Unknown
- Start
- Feb 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dimethyl fumarate in multiple sclerosis (MS). Status: unknown.
02
Drugs
dimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03092544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03092544.